Mitra Rezaei
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 19
- SARS-CoV-2 and COVID-19 Research 14
- Epidemiology 10
- Mycobacterium research and diagnosis 3
- Co-authors
- Majid Marjani (21 shared papers)Shima Mahmoudi (4 shared papers)Seyed Ali Ziai (8 shared papers)Davood Mansouri (3 shared papers)Esmaeil Mortaz (3 shared papers)Nahal Mansouri (1 shared paper)Sajad Fakhri (1 shared paper)Ramin Pouriran (2 shared papers)
- Journals
- Scientific Reports (2 papers)International Archives of Allergy and Immunology (2 papers)International Immunopharmacology (2 papers)Journal of Cellular Physiology (1 paper)Climate Risk Management (1 paper)
- Partner nations
- IranUnited StatesUnited Kingdom
In The Last Decade
Mitra Rezaei
47 papers receiving 351 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 212
- Neurology 79
- Critical Care and Intensive Care Medicine 16
- Immunology 53
- Dermatology 16
Countries citing papers authored by Mitra Rezaei
This map shows the geographic impact of Mitra Rezaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitra Rezaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitra Rezaei more than expected).
Fields of papers citing papers by Mitra Rezaei
This network shows the impact of papers produced by Mitra Rezaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitra Rezaei. The network helps show where Mitra Rezaei may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitra Rezaei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 49 | |
| 2 | 2020 | 33 | |
| 3 | 2021 | 31 | |
| 4 | 2020 | 30 | |
| 5 | 2021 | 27 | |
| 6 | 2021 | 18 | |
| 7 | 2020 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 10 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 8 | |
| 16 | Bruton's Tyrosine Kinase: A Promising Target for the Treatment of COVID-19. | 2020 | 6 |
| 17 | A Novel Coronavirus Disease (COVID-19): a Review of Host Cell Signaling Pathways. | 2020 | 5 |
| 18 | 2020 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2020 | 4 |
About Mitra Rezaei
Mitra Rezaei is a scholar working on Infectious Diseases, Epidemiology, Radiology, Nuclear Medicine and Imaging, Neurology and Oncology, having authored 59 papers that have together received 359 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Long-Term Effects of COVID-19 (8 papers), COVID-19 diagnosis using AI (3 papers), Disaster Management and Resilience (3 papers), Flood Risk Assessment and Management (3 papers), Cancer-related molecular mechanisms research (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Infectious Diseases (212 citations), Neurology (79 citations), Critical Care and Intensive Care Medicine (16 citations), Immunology (53 citations) and Dermatology (16 citations). Mitra Rezaei has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Majid Marjani, Shima Mahmoudi, Seyed Ali Ziai, Davood Mansouri, Esmaeil Mortaz, Nahal Mansouri, Sajad Fakhri, Ramin Pouriran, Elham Askari and Saghar Barati. Their work appears in journals such as Scientific Reports, International Archives of Allergy and Immunology, International Immunopharmacology, Journal of Cellular Physiology and Climate Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.